A 65-yr. old male who has multiple myeloma is currently rece…

A 65-yr. old male who has multiple myeloma is currently receiving monoclonal anti-CD38 immunotherapy (Daratumumab).                                                      Which of the following is used to treat reagent red cells in an effort to prevent interference of this drug with testing in the blood bank?